X4 Pharmaceuticals (XFOR) Depreciation and Depletion (2023 - 2025)
X4 Pharmaceuticals (XFOR) posted Depreciation and Depletion of $168000.0 for Q2 2025, down 41.87% on a QoQ basis from $289000.0 in Q1 2025, and up 143.48% year-over-year from $69000.0 in Q2 2024.
X4 Pharmaceuticals (XFOR) Depreciation and Depletion (2023 - 2025) Analysis & Trends
X4 Pharmaceuticals' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $168000.0 for Q2 2025.
- Quarterly Depreciation and Depletion rose 143.48% year-over-year to $168000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $626000.0 (up 125.18% YoY) and the FY2025 annual result came in at $500000.0, up 66.67% from the prior year.
- Depreciation and Depletion was $168000.0 for Q2 2025 at X4 Pharmaceuticals, down from $289000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $289000.0 in Q1 2025 and bottomed at $43000.0 in Q4 2023.
- A 3-year average of $113000.0 and a median of $84500.0 in 2024 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion fell 23.08% — and 2025, when it jumped 366.13%.
- X4 Pharmaceuticals' Depreciation and Depletion stood at $43000.0 in 2023, then surged by 106.98% to $89000.0 in 2024, then surged by 88.76% to $168000.0 in 2025.
- Business Quant data shows XFOR's Depreciation and Depletion at $168000.0 in Q2 2025, $289000.0 in Q1 2025, and $89000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | - |
| 10 | X4 Pharmaceuticals | 165.58 Mn | -51.47 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 104,000.00 |
| Sep 30, 2023 | 104,000.00 |